Literature DB >> 16706972

Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

A P Reiner1, C L Carty, C S Carlson, J Y Wan, M J Rieder, J D Smith, K Rice, M Fornage, C E Jaquish, O D Williams, R P Tracy, C E Lewis, D S Siscovick, E Boerwinkle, D A Nickerson.   

Abstract

BACKGROUND: Previous genotype-phenotype association studies of fibrinogen have been limited by incomplete knowledge of genomic sequence variation within and between major ethnic groups in FGB, FGA, and FGG.
METHODS: We characterized the linkage disequilibrium patterns and haplotype structure across the human fibrinogen gene locus in European- and African-American populations. We analyzed the association between common polymorphisms in the fibrinogen genes and circulating levels of both 'functional' fibrinogen (measured by the Clauss clotting rate method) and total fibrinogen (measured by immunonephelometry) in a large, multi-center, bi-racial cohort of young US adults.
RESULTS: A common haplotype tagged by the A minor allele of the well-studied FGB-455 G/A promoter polymorphism (FGB 1437) was confirmed to be strongly associated with increased plasma fibrinogen levels. Two non-coding variants specific to African-American chromosomes, FGA 3845 A and FGG 5729 G, were each associated with lower plasma fibrinogen levels. In European-Americans, a common haplotype tagged by FGA Thr312Ala and several other variant alleles across the fibrinogen gene locus was strongly associated with decreased fibrinogen levels as measured by functional assay, but not by immunoassay. Overall, common polymorphisms within the three fibrinogen genes explain < 2% of the variability in plasma fibrinogen concentration.
CONCLUSIONS: In young adults, fibrinogen multi-locus genotypes are associated with plasma fibrinogen levels. The specific single nucleotide polymorphism and haplotype patterns for these associations differ according to population and also according to phenotypic assay. It is likely that a substantial proportion of the heritable component of plasma fibrinogen concentration is due to genetic variation outside the three fibrinogen genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706972     DOI: 10.1111/j.1538-7836.2006.01907.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  24 in total

1.  Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).

Authors:  Christina L Wassel; Leslie A Lange; Brendan J Keating; Kira C Taylor; Andrew D Johnson; Cameron Palmer; Lindsey A Ho; Nicholas L Smith; Ethan M Lange; Yun Li; Qiong Yang; Joseph A Delaney; Weihong Tang; Geoffrey Tofler; Susan Redline; Herman A Taylor; James G Wilson; Russell P Tracy; David R Jacobs; Aaron R Folsom; David Green; Christopher J O'Donnell; Alexander P Reiner
Journal:  Blood       Date:  2010-10-26       Impact factor: 22.113

2.  Replication and characterisation of genetic variants in the fibrinogen gene cluster with plasma fibrinogen levels and haematological traits in the Third National Health and Nutrition Examination Survey.

Authors:  Janina M Jeff; Kristin Brown-Gentry; Dana C Crawford
Journal:  Thromb Haemost       Date:  2012-01-25       Impact factor: 5.249

3.  Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.

Authors:  Elena V Zholdybayeva; Yerkebulan A Talzhanov; Akbota M Aitkulova; Pavel V Tarlykov; Gulmira N Kulmambetova; Aisha N Iskakova; Aliya U Dzholdasbekova; Olga A Visternichan; Dana Zh Taizhanova; Yerlan M Ramanculov
Journal:  Hum Genomics       Date:  2016-06-08       Impact factor: 4.639

4.  Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies.

Authors:  N L Smith; J A Heit; W Tang; M Teichert; D I Chasman; P-E Morange
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

Review 5.  Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis.

Authors:  Berthold Hoppe; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

6.  Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study.

Authors:  D Green; C Chan; J Kang; K Liu; P Schreiner; N S Jenny; R P Tracy
Journal:  J Thromb Haemost       Date:  2009-12-15       Impact factor: 5.824

7.  Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation.

Authors:  Dmitry A Zateyshchikov; Alexey N Brovkin; Dimitry A Chistiakov; Valery V Nosikov
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

8.  Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.

Authors:  Cara L Carty; Patrick Heagerty; Susan R Heckbert; Gail P Jarvik; Leslie A Lange; Mary Cushman; Russell P Tracy; Alexander P Reiner
Journal:  Ann Hum Genet       Date:  2010-01       Impact factor: 1.670

9.  Systemic inflammation in young adults is associated with abnormal lung function in middle age.

Authors:  Ravi Kalhan; Betty T Tran; Laura A Colangelo; Sharon R Rosenberg; Kiang Liu; Bharat Thyagarajan; David R Jacobs; Lewis J Smith
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

10.  LPA and PLG sequence variation and kringle IV-2 copy number in two populations.

Authors:  Dana C Crawford; Ze Peng; Jan-Fang Cheng; Dario Boffelli; Magdalena Ahearn; Dan Nguyen; Tristan Shaffer; Qian Yi; Robert J Livingston; Mark J Rieder; Deborah A Nickerson
Journal:  Hum Hered       Date:  2008-07-09       Impact factor: 0.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.